Previously we reported high tumor uptake of exogenous choline in rodent brain tumor models when using Deuterium Metabolic Imaging (DMI) during intravenous infusion of [2H9]-choline. The small differences in chemical shifts of [2H9]-labeled choline, phosphocholine, glycerophosphocholine and betaine exclude accurate peak assignment, and therefore it is unclear whether blood-borne choline is metabolized intracellularly. Using different 2H-labeling strategies of choline and high resolution 2H NMR in tumor tissue extracts we identified the choline-containing metabolites observed during intravenous infusion, as well as after 24 hrs.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords